- https://www.novartis.com/stories/keeping-heart-patients-heart-everything-we-do
For over 60 years Novartis has been committed to helping people with cardiovascular disease and we remain steadfast in that commitment to this day.
- https://www.novartis.com/stories/let-there-be-sight
- https://www.novartis.com/stories/loss-friend-liver-cancer-sharpens-focus-experimental-therapy
A Novartis experimental drug in clinical trial aims to block liver cancer growth
- https://www.novartis.com/stories/killing-three-diseases-one-stone-lab
Novartis researchers have discovered a compound that is showing promise against three parasites that cause three neglected diseases.
- https://www.novartis.com/stories/leveraging-livers-ability-heal-scarred-tissue
A reversal in thinking about the reversibility of liver damage is changing the field of hepatology.
- https://www.novartis.com/stories/making-possible-stepping-toward-future-cell-and-gene-therapy
These stories offer a glimpse into the lives of people touched by a new era of medicine.
- https://www.novartis.com/stories/meet-achim-leading-data42-program
The recently appointed leader of the Novartis’ digital research and development platform data42 is a strong believer that data and digital technologies will change the path of medical science.
- https://www.novartis.com/stories/mutant-protein-spreads-through-neural-circuit-huntingtons-disease
Read how a genetics postdoctoral researcher finds Huntington's mutation travels through neural circuits.
- https://www.novartis.com/stories/moving-from-speculation-science-during-pandemic
Florencia Segal’s experiences prepared her to lead the rapid design of a large COVID-19 clinical trial.
- https://www.novartis.com/stories/breaking-vicious-cycle-inflammation
Novartis researchers aim to quash inflammation to treat chronic disease.
Pagination
- ‹ Previous page
- 1
- 2
- 3
- 4
- 5
- 6
- 7
- …
- 38
- › Next page